July 7, 2016 by Dan • FREE ACCESS

Lat Friday on CNBC’s Options Action, we discussed the under-performance of Biotech stocks in the first half of 2016. Meg Tirrell highlighted the large cash balances of mega-cap biotechs, and the potential for a second half …

Continue reading
December 17, 2015 by Dan • FREE ACCESS

The Fed is doing their best to orchestrate a soft landing for their rate lift-off.  Yeah, that makes no sense. But I made it up myself and it makes me laugh. The FOMC are quick learners …

Continue reading
July 8, 2015 by Dan • FREE ACCESS

In case you missed (sarcasm font needed), there is some funky stuff going on in China as it relates to their stock markets. Government regulators in an attempt to stabilize the sell off have halted …

Continue reading
May 26, 2015 by Dan • FREE ACCESS

Friday afternoon CNBC’s David Faber confirmed the speculation surrounding a potential bid by Microsoft (MSFT) for Salesforce.com (CRM): Microsoft and Salesforce.com had significant talks earlier this spring about a purchase of Salesforce by Microsoft, according …

Continue reading
April 7, 2015 by Dan • FREE ACCESS

I’ll keep this short and sweet. Yesterday, the market began with early weakness on the heels of Friday’s much worse than expected March Jobs data. About 15 minutes into the trading day those losses were erased …

Continue reading